196 related articles for article (PubMed ID: 38181024)
1. Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
Li R; Chen Y; Yang B; Li Z; Wang S; He J; Zhou Z; Li X; Li J; Sun Y; Guo X; Wang X; Wu Y; Zhang W; Guo G
PLoS One; 2024; 19(1):e0295346. PubMed ID: 38181024
[TBL] [Abstract][Full Text] [Related]
2. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
3. Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature.
Yu K; Tian Q; Feng S; Zhang Y; Cheng Z; Li M; Zhu H; He J; Li M; Xiong X
Cell Signal; 2024 Jul; 119():111168. PubMed ID: 38599441
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer.
Gu P; Yang D; Zhu J; Zhang M; He X
Medicine (Baltimore); 2022 Feb; 101(5):e28788. PubMed ID: 35119046
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
Li W; Lv D; Yao J; Chen B; Liu H; Li W; Xu C; Li Z
PLoS One; 2023; 18(9):e0291024. PubMed ID: 37733705
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
7. CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer.
Li Z; Liu Z; Li C; Liu Q; Tan B; Liu Y; Zhang Y; Li Y
Transl Cancer Res; 2021 Jul; 10(7):3404-3417. PubMed ID: 35116645
[TBL] [Abstract][Full Text] [Related]
8. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract][Full Text] [Related]
9. The role of costimulatory molecules in glioma biology and immune microenvironment.
Wang J; Wang Z; Jia W; Gong W; Dong B; Wang Z; Zhou M; Tian C
Front Genet; 2022; 13():1024922. PubMed ID: 36437961
[No Abstract] [Full Text] [Related]
10. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
11. Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma.
Guo R; Ying J; Jia L; Zhuang N; Jiang H; Xiong J
J Cosmet Dermatol; 2022 Nov; 21(11):6034-6048. PubMed ID: 35575979
[TBL] [Abstract][Full Text] [Related]
12. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
13. The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
Jin X; Sun ZQ; Zhou GL; Li GJ; Deng SF
Dis Markers; 2022; 2022():2184867. PubMed ID: 35386230
[TBL] [Abstract][Full Text] [Related]
14. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
15. Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma.
Jiang D; Li Y; Cao J; Sheng L; Zhu X; Xu M
Front Oncol; 2022; 12():779175. PubMed ID: 35237510
[TBL] [Abstract][Full Text] [Related]
16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
Wang Z; Xu J; Zhang S; Chang L
Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
[TBL] [Abstract][Full Text] [Related]
19. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods.
Zhang H; Huang Y; Yang E; Gao X; Zou P; Sun J; Tian Z; Bao M; Liao D; Ge J; Yang Q; Li X; Zhang Z; Luo P; Jiang X
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
